Compare Quantumscape Corp (QS) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quantumscape Corp vs 22nd Century Group Inc — how do they compare? Quantumscape Corp trades at $5.22 (market cap $3.21B), while 22nd Century Group Inc trades at $2.17 (market cap $1.50M). The key difference: Quantumscape Corp is far larger — about 2140× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.
| QS | XXII | |
|---|---|---|
Market Cap | $3.21B | $1.50M |
Sector | Consumer Cyclical | Technology |
52-Week High | $18.44 | $594.00 |
52-Week Low | $4.89 | $2.13 |
Enterprise Value | $2.42B | -$2.81M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QuantumScape (QS) trades at $5.59, up 2.01% today but near its 52-week low, with a bearish technical signal from moving averages. The company reported a net loss of $435.05M for 2025, with negative ROE and ROA, and has no revenue as it develops solid-state batteries. Recent news highlights insider sales and delayed commercialization to 2029, while institutional interest includes new positions from Bank of New York Mellon (September 3, 2026).
Outlook remains high-risk due to pre-revenue status and execution delays, with analyst consensus cautious (72.7% hold, 27.3% sell). Opportunities hinge on battery technology success, but investors face substantial volatility and competitive threats from automakers. Cash flow trends show reliance on financing, with net cash flow turning positive in 2025 at $85.27M after prior losses.
XXII trades at $2.29, down 4.58% today, with a bearish technical signal from moving averages but oversold RSI readings. The company reported a Q2 2026 EPS miss of -15.6 versus -6 expected, with negative gross and net income margins. Recent news highlights VLN brand expansion and a 20:1 reverse stock split effective June 12, 2026.
Outlook is challenged by persistent losses and high cash burn, though analyst consensus is 75% buy. Key risks include execution on commercialization and profitability turnaround. The stock's low valuation multiples may attract speculative interest if operational improvements materialize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quantumscape Corp
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
